Proton Beam Therapy in the Treatment of Esophageal Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 19, 2018

Primary Completion Date

September 13, 2022

Study Completion Date

August 9, 2026

Conditions
Esophagus CancerEsophageal CancerCancer of the Esophagus
Interventions
RADIATION

Proton beam therapy

"* The daily prescription dose will be 1.8 or 2 Gy RBE (Relative Biologic Equivalence) to be delivered to the periphery of the planning target volume (PTV).~* The Mevion S-250 Proton Radiation Beam Therapy System will be used."

OTHER

Patient-Reported Outcome Measures

-Prior to start of therapy, end of chemoradiation (day of end of treatment or up to 1 week after), 8 weeks, 4, 6, 9, and 12-months following end of chemoradiation

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT03482791 - Proton Beam Therapy in the Treatment of Esophageal Cancer | Biotech Hunter | Biotech Hunter